The latest PEG ratio for ERGO is -0.01. That is below the sector sector average of 10.05. Investors often review this figure alongside Entia Biosciences's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ERGO currently prints -0.01 for PEG ratio, while the sector average sits near 10.05. That is roughly 100.1% below the sector mean. Large gaps often invite a closer look at Entia Biosciences's growth, margins, and balance sheet.

A PEG ratio of -0.01 for Entia Biosciences is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with ERGO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ERGO's PEG ratio (-0.01), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.